# Lineage Cell Therapeutics, Inc.: Form 8-K, filed Mar 7, 2024

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 8-K
- Filed: 2024-03-07
- Accepted by EDGAR: Mar 7, 2024, 16:10 ET
- Period: 2024-03-07
- Accession: 0000950170-24-027951
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000095017024027951/lctx-20240307.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000095017024027951/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000095017024027951/lctx-20240307.htm

Filed Mar 7, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-027951. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.